Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02443324 |
|---|---|
| Brief Title: | A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract Cancer |
| First Submitted : | May 11, 2015 |
| First Submitted that Met QC Criteria : | May 11, 2015 |
| First Posted : | May 13, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | August 17, 2022 |
| Last Update Posted : | August 18, 2022 |